Details for New Drug Application (NDA): 050740
✉ Email this page to a colleague
The generic ingredient in AMBISOME is amphotericin b. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amphotericin b profile page.
Summary for 050740
Tradename: | AMBISOME |
Applicant: | Astellas |
Ingredient: | amphotericin b |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 050740
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AMBISOME | amphotericin b | INJECTABLE, LIPOSOMAL;INJECTION | 050740 | NDA | Astellas Pharma US, Inc. | 0469-3051 | 0469-3051-30 | 12.5 mL in 1 VIAL, SINGLE-DOSE (0469-3051-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE, LIPOSOMAL;INJECTION | Strength | 50MG/VIAL | ||||
Approval Date: | Aug 11, 1997 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 050740
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astellas | AMBISOME | amphotericin b | INJECTABLE, LIPOSOMAL;INJECTION | 050740-001 | Aug 11, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Astellas | AMBISOME | amphotericin b | INJECTABLE, LIPOSOMAL;INJECTION | 050740-001 | Aug 11, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription